English   español  

Browsing by Author Albanell, Joan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg2016C-Jun N-terminal kinase inactivation by mitogen-activated protein kinase phosphatase 1 determines resistance to taxanes and anthracyclines in breast cancerRincón, Raúl; Zazo, Sandra; Manso, Rebeca; Perona Abellón, Rosario CSIC ORCID; Albanell, Joan; Madoz-Gúrpide, Juan CSIC; Rojo, Federicoartículo
closedAccessaccesoRestringido.pdf.jpgFeb-2020Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patientsCortés, Javier; Ciruelos, Eva María; Pérez-García, José Manuel; Albanell, Joan; García-Estévez, Laura; Ruiz-Borrego, Manuel; Espinosa, Ruth; Gallegos, Isabel; González, Santiago; Álvarez, Isabel; Llombart, Antonioartículo de revisión
closedAccessaccesoRestringido.pdf.jpg2017Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancerSabbaghi, Mohammad A.; Gil-Gómez, Gabriel; Guardia, Cristina; Servitja, Sonia; Arpí, Oriol; García-Alonso, Sara; Menendez, Silvia; Arumi-Uria, Montserrat; Serrano, Laia; Salido, Marta; Muntasell, Aura; Martínez-García, Maria; Zazo, Sandra; Chamizo, Crsitina; Gonzalez-Alonso, Paula; Madoz-Gúrpide, Juan CSIC; Eroles, Pilar; Arribas, Joaquín; Tusquets, Ignasi; Lluch, Ana; Pandiella, Atanasio CSIC ORCID CVN ; Rojo, Federico; Rovira, Ana; Albanell, Joanartículo
openAccessOPINION Galectins in prostate and bladder cancer.pdf.jpg23-Apr-2019Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunitiesMartinez-Bosch, Neus; Rodriguez-Vida, Alejo; Juanpere, Núria; Lloreta, Josep; Rovira, Ana; Albanell, Joan; Bellmunt, Joaquim; Navarro, Pilar CSICartículo
openAccessInhibition of the Canonical.pdf.jpg2007Inhibition of the canonical IKK/NFκB pathway sensitizes human cancer cells to doxorubicinRodriguez-Fanjul, V. CSIC ORCID; Perona Abellón, Rosario CSIC ORCID; Albanell, Joanartículo
closedAccessaccesoRestringido.pdf.jpg2009Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicinCortés-Sempere, María; Rodriguez-Fanjul, V. CSIC ORCID; Sánchez-Pérez, Isabel; Perona Abellón, Rosario CSIC ORCID; Albanell, Joanartículo
closedAccessaccesoRestringido.pdf.jpg2009MKP1 repression is required for the chemosensitizing effects of NF-κB and PI3K inhibitors to cisplatin in non-small cell lung cancerCortés-Sempere, María; Rodriguez-Fanjul, V. CSIC ORCID; Belda-Iniesta, Cristobal; Cejas, Paloma; Machado-Pinilla, R. CSIC; Manguan-García, Cristina CSIC; Sánchez-Pérez, Isabel; Nistal, Manuel; Moratilla, Carmen CSIC; Castro Carpeño, Javier de; González Barón, Manuel; Albanell, Joan; Perona Abellón, Rosario CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg15-Sep-2021Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancerGuardia, Cristina; Bianchini, Giampaolo; Arpí, Oriol; Menendez, Silvia; Casadevall, David; Galbardi, Barbara; Dugo, Matteo; Servitja, Sonia; Montero, Juan Carlos CSIC ORCID; Soria-Jiménez, Luis; Sabbaghi, Mohammad A.; Peña, Raúl; Madoz-Gúrpide, Juan CSIC; Lloveras, Belén; Lluch, Ana; Eroles, Pilar; Arribas, Joaquín; Pandiella, Atanasio CSIC ORCID CVN ; Gianni, Luca; Rojo, Federico; Rovira, Ana; Albanell, Joanartículo